Prostate Cancer
Leuprolide acetate is available as subcutaneous extended-release injection
Published in Medical Letter on the CDC and FDA, March 5th, 2006
According to a report from the United States, "Androgen deprivation therapy is a mainstay for the treatment of advanced prostate cancer. Hormonal therapy commonly consists of injection of gonadotropin hormone-releasing hormone agonists."
"Based on the need for improved convenience of administration, a novel formulation of leuprolide acetate (Ellgard; Atrix Laboratories Inc. and Sanofi Aventis) which incorporates a mixture of selected polymers and solvents to achieve sustained drug delivery after subcutaneous injection, was developed," reported Michael C. Cox and colleagues...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Anthrax Vaccines
Effects of storage on plasmid stability in Bacillus anthracis are reported - Epidemiology
Prevalence of Staphylococcus aureus nasal colonization is high in U.S. - Epidemiology
Report examines prevalence of hepatitis A virus infection in U.S. population - HIV/AIDS Risk Factors
Effectiveness of community outreach to prevent HIV/AIDS in drug users is examined - HIV/AIDS Risk Factors
Report presents results of the Expanded HIV Risk Factor Assessment Project - Addiction Medicine
Depictions of substance use in reality television send mixed messages - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
